Quantum BioPharma Ltd
NASDAQ:QNTM
Fundamental Analysis

Revenue & Expenses Breakdown
Quantum BioPharma Ltd
Balance Sheet Decomposition
Quantum BioPharma Ltd
Current Assets | 9.9m |
Cash & Short-Term Investments | 3.5m |
Receivables | 3.4m |
Other Current Assets | 3m |
Non-Current Assets | 4.9m |
Long-Term Investments | 2.2k |
PP&E | 109.3k |
Intangibles | 4.8m |
Free Cash Flow Analysis
Quantum BioPharma Ltd
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Quantum BioPharma Ltd
Revenue
|
0
USD
|
Operating Expenses
|
-17.3m
USD
|
Operating Income
|
-17.3m
USD
|
Other Expenses
|
-3.4m
USD
|
Net Income
|
-20.7m
USD
|
QNTM Profitability Score
Profitability Due Diligence
Quantum BioPharma Ltd's profitability score is 21/100. The higher the profitability score, the more profitable the company is.
Score
Quantum BioPharma Ltd's profitability score is 21/100. The higher the profitability score, the more profitable the company is.
QNTM Solvency Score
Solvency Due Diligence
Quantum BioPharma Ltd's solvency score is 51/100. The higher the solvency score, the more solvent the company is.
Score
Quantum BioPharma Ltd's solvency score is 51/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
QNTM Price Targets Summary
Quantum BioPharma Ltd
Dividends
Current shareholder yield for QNTM is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?